Literature DB >> 33168658

Oncolytic Reovirus (pelareorep) Induces Autophagy in KRAS-mutated Colorectal Cancer.

Jeeshan Jiffry1, Thongthai Thavornwatanayong1, Sanjay Goel2,3, Radhashree Maitra2,3,4, Devika Rao3, Elisha J Fogel4, Durvanand Saytoo1, Rishika Nahata1, Hillary Guzik1, Imran Chaudhary3, Titto Augustine1.   

Abstract

PURPOSE: To explore the effects of pelareorep on autophagy in multiple models of colorectal cancer, including patient-derived peripheral blood mononuclear cells (PBMCs). EXPERIMENTAL
DESIGN: HCT116 [KRAS mutant (mut)] and Hke3 [KRAS wild-type (WT)] cells were treated with pelareorep (multiplicity of infection, 5) and harvested at 6 and 9 hours. LC3 A/B expression was determined by immunofluorescence and flow cytometry; five autophagic proteins were analyzed by Western blotting. The expression of 88 autophagy genes was determined by qRT-PCR. Syngeneic mouse models, CT26/Balb-C (KRAS mut) and MC38/C57B6 (KRAS WT), were developed and treated with pelareorep (10 × 106 plaque-forming unit/day) intraperitoneally. Protein and RNA were extracted from harvested tumor tissues. PBMCs from five experimental and three control patients were sampled at 0 (pre) and 48 hours, and on days 8 and 15. The gene expression normalized to "pre" was determined using 2-ΔΔC t method.
RESULTS: Pelareorep induced significant upregulation of LC3 A/B in HCT116 as compared with Hke3 cells by immunofluorescence (3.24 × and 8.67 ×), flow cytometry (2.37 × and 2.58 ×), and autophagosome formation (2.02 × and 1.57 ×), at 6 and 9 hours, respectively; all P < 0.05. Western blot analysis showed an increase in LC3 A/B (2.38 × and 6.82 ×) and Beclin1 (1.17 × and 1.24 ×) at 6 and 9 hours, ATG5 (2.4 ×) and P-62 (1.52 ×) at 6 hours, and VPS-34 (1.39 ×) at 9 hours (all P < 0.05). Induction of 13 transcripts in cell lines (>4 ×; 6 and 9 hours; P < 0.05), 12 transcripts in CT26 (qRT-PCR), and 14 transcripts in human PBMCs (P < 0.05) was observed. LC3 A/B, RICTOR, and RASD1 expression was upregulated in all three model systems.
CONCLUSIONS: Pelareorep hijacks host autophagic machinery in KRAS-mut conditions to augment its propagation and preferential oncolysis of the cancer cells. ©2020 American Association for Cancer Research.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 33168658      PMCID: PMC8130598          DOI: 10.1158/1078-0432.CCR-20-2385

Source DB:  PubMed          Journal:  Clin Cancer Res        ISSN: 1078-0432            Impact factor:   12.531


  46 in total

Review 1.  Autophagy and tumorigenesis.

Authors:  Nan Chen; Jayanta Debnath
Journal:  FEBS Lett       Date:  2009-12-24       Impact factor: 4.124

2.  A Rictor-Myo1c complex participates in dynamic cortical actin events in 3T3-L1 adipocytes.

Authors:  G Nana Hagan; Yenshou Lin; Mark A Magnuson; Joseph Avruch; Michael P Czech
Journal:  Mol Cell Biol       Date:  2008-04-21       Impact factor: 4.272

Review 3.  The Beclin 1 network regulates autophagy and apoptosis.

Authors:  R Kang; H J Zeh; M T Lotze; D Tang
Journal:  Cell Death Differ       Date:  2011-02-11       Impact factor: 15.828

4.  Efficacy and safety evaluation of human reovirus type 3 in immunocompetent animals: racine and nonhuman primates.

Authors:  Wen Qing Yang; Xueqing Lun; Cheryl Ann Palmer; M Elizabeth Wilcox; Huong Muzik; Zhong Qiao Shi; Richard Dyck; Matt Coffey; Brad Thompson; Mark Hamilton; Sandra G Nishikawa; Penny M A Brasher; Kevin Fonseca; David George; N Berry Rewcastle; Randal N Johnston; Doug Stewart; Patrick W K Lee; Donna L Senger; Peter A Forsyth
Journal:  Clin Cancer Res       Date:  2004-12-15       Impact factor: 12.531

Review 5.  Reovirus: a targeted therapeutic--progress and potential.

Authors:  Radhashree Maitra; Mohammad H Ghalib; Sanjay Goel
Journal:  Mol Cancer Res       Date:  2012-10-04       Impact factor: 5.852

6.  Regulation of PP2Cm expression by miRNA-204/211 and miRNA-22 in mouse and human cells.

Authors:  Bang-fen Pan; Chen Gao; Shu-xun Ren; Yi-bin Wang; Hai-peng Sun; Mei-yi Zhou
Journal:  Acta Pharmacol Sin       Date:  2015-11-23       Impact factor: 6.150

7.  Elucidation of Pelareorep Pharmacodynamics in A Phase I Trial in Patients with KRAS-Mutated Colorectal Cancer.

Authors:  Sanjay Goel; Allyson J Ocean; Ruwan Y Parakrama; Mohammad H Ghalib; Imran Chaudhary; Umang Shah; Sengottuvel Viswanathan; Himanshu Kharkwal; Matthew Coffey; Radhashree Maitra
Journal:  Mol Cancer Ther       Date:  2020-03-10       Impact factor: 6.261

8.  Immune characterization of metastatic colorectal cancer patients post reovirus administration.

Authors:  Ruwan Parakrama; Elisha Fogel; Carol Chandy; Titto Augustine; Matt Coffey; Lydia Tesfa; Sanjay Goel; Radhashree Maitra
Journal:  BMC Cancer       Date:  2020-06-18       Impact factor: 4.430

Review 9.  Autophagy Modulation in Cancer: Current Knowledge on Action and Therapy.

Authors:  Mija Marinković; Matilda Šprung; Maja Buljubašić; Ivana Novak
Journal:  Oxid Med Cell Longev       Date:  2018-01-31       Impact factor: 6.543

10.  Concomitant targeting of the mTOR/MAPK pathways: novel therapeutic strategy in subsets of RICTOR/KRAS-altered non-small cell lung cancer.

Authors:  Dennis Ruder; Vassiliki Papadimitrakopoulou; Kazuhiko Shien; Carmen Behrens; Neda Kalhor; Huiqin Chen; Li Shen; J Jack Lee; Waun Ki Hong; Ximing Tang; Luc Girard; John D Minna; Lixia Diao; Jing Wang; Barbara Mino; Pamela Villalobos; Jaime Rodriguez-Canales; Nana E Hanson; James Sun; Vincent Miller; Joel Greenbowe; Garrett Frampton; Roy S Herbst; Veera Baladandayuthapani; Ignacio I Wistuba; Julie G Izzo
Journal:  Oncotarget       Date:  2018-09-21
View more
  9 in total

1.  Oncolytic Virus Affects the RAS Pathway in Cancer: RNA Sequence Analysis.

Authors:  Avishai Samouha; Elisha J Fogel; Sanjay Goel; Radhashree Maitra
Journal:  J Oncol Res Ther       Date:  2021-10-27

Review 2.  Reovirus Activated Cell Death Pathways.

Authors:  Carly DeAntoneo; Pranav Danthi; Siddharth Balachandran
Journal:  Cells       Date:  2022-05-27       Impact factor: 7.666

3.  PIK3C3 Inhibition Promotes Sensitivity to Colon Cancer Therapy by Inhibiting Cancer Stem Cells.

Authors:  Balawant Kumar; Rizwan Ahmad; Swagat Sharma; Saiprasad Gowrikumar; Mark Primeaux; Sandeep Rana; Amarnath Natarajan; David Oupicky; Corey R Hopkins; Punita Dhawan; Amar B Singh
Journal:  Cancers (Basel)       Date:  2021-04-30       Impact factor: 6.639

Review 4.  Role of Myeloid Cells in Oncolytic Reovirus-Based Cancer Therapy.

Authors:  Vishnupriyan Kumar; Michael A Giacomantonio; Shashi Gujar
Journal:  Viruses       Date:  2021-04-10       Impact factor: 5.048

5.  Transcriptome Signature of Immune Cells Post Reovirus Treatment in KRAS Mutated Colorectal Cancer.

Authors:  Elisha J Fogel; Avishai Samouha; Sanjay Goel; Radhashree Maitra
Journal:  Cancer Manag Res       Date:  2021-08-27       Impact factor: 3.989

Review 6.  Autophagy in Tumor Immunity and Viral-Based Immunotherapeutic Approaches in Cancer.

Authors:  Ali Zahedi-Amiri; Kyle Malone; Shawn T Beug; Tommy Alain; Behzad Yeganeh
Journal:  Cells       Date:  2021-10-06       Impact factor: 7.666

Review 7.  Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option.

Authors:  Yi Ren; Jia-Meng Miao; Yuan-Yuan Wang; Zheng Fan; Xian-Bin Kong; Long Yang; Gong Cheng
Journal:  Front Immunol       Date:  2022-07-15       Impact factor: 8.786

8.  Reovirus enhances cytotoxicity of natural killer cells against colorectal cancer via TLR3 pathway.

Authors:  Shiqi Long; Yangzhuo Gu; Yuanyuan An; Xiaojin Lin; Xiaoqing Chen; Xianyao Wang; Chunxiang Liao; Weiwei Ouyang; Nianxue Wang; Zhixu He; Xing Zhao
Journal:  J Transl Med       Date:  2021-05-01       Impact factor: 8.440

Review 9.  Therapeutic Targets of KRAS in Colorectal Cancer.

Authors:  Shafia Rahman; Shimon Garrel; Michael Gerber; Radhashree Maitra; Sanjay Goel
Journal:  Cancers (Basel)       Date:  2021-12-11       Impact factor: 6.639

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.